Literature DB >> 10686482

The human T cell receptor beta variable (TRBV) genes.

G Folch1, M P Lefranc.   

Abstract

'Human T Cell Receptor Beta Variable (TRBV) Genes', the seventh report of the 'IMGT Locus on Focus' section, comprises four tables: (1) 'Number of human germline TRBV genes at 7q35 and potential repertoire'; (2) 'Human germline TRBV genes at 7q35'; (3) 'Human TRBV orphons on chromosome 9 (9p21)', and (4) 'Human TRBV allele table'. These tables are available at the IMGT Marie-Paule page from IMGT, the international ImMunoGeneTics database (http://imgt.cines. fr: 8104) created by Marie-Paule Lefranc, Université Montpellier II, CNRS, France. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh：

Year:  2000        PMID： 10686482     DOI： 10.1159/000019123

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN： 0254-9670


  26 in total

1.  Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing.

Authors:  J Douglas Freeman; René L Warren; John R Webb; Brad H Nelson; Robert A Holt
Journal:  Genome Res       Date:  2009-06-18       Impact factor: 9.043

Review 2.  Human gamma delta T cells: Evolution and ligand recognition.

Authors:  Erin J Adams; Siyi Gu; Adrienne M Luoma
Journal:  Cell Immunol       Date:  2015-05-06       Impact factor: 4.868

3.  Quantitative analysis and clonal characterization of T-cell receptor β repertoires in patients with advanced non-small cell lung cancer treated with cancer vaccine.

Authors:  Tu Mai; Atsushi Takano; Hiroyuki Suzuki; Takashi Hirose; Takahiro Mori; Koji Teramoto; Kazuma Kiyotani; Yusuke Nakamura; Yataro Daigo
Journal:  Oncol Lett       Date:  2017-05-05       Impact factor: 2.967

4.  Characterization of the cryoablation-induced immune response in kidney cancer patients.

Authors:  Taigo Kato; Tomoyuki Iwasaki; Motohide Uemura; Akira Nagahara; Hiroki Higashihara; Keigo Osuga; Yuji Ikeda; Kazuma Kiyotani; Jae-Hyun Park; Norio Nonomura; Yusuke Nakamura
Journal:  Oncoimmunology       Date:  2017-05-16       Impact factor: 8.110

5.  Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function.

Authors:  Ester B M Remmerswaal; Paul L Klarenbeek; Nuno L Alves; Marieke E Doorenspleet; Barbera D C van Schaik; Rebecca E E Esveldt; Mirza M Idu; Ester M M van Leeuwen; Nelly van der Bom-Baylon; Antoine H C van Kampen; Sven D Koch; Hanspeter Pircher; Frederike J Bemelman; Anja Ten Brinke; Frank Baas; Ineke J M Ten Berge; Rene A W van Lier; Niek de Vries
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

6.  Cytomegalovirus-specific CD8+ T cells targeting different peptide/HLA combinations demonstrate varying T-cell receptor diversity.

Authors:  Sandra Giest; Alasdair McWhinnie; Marie-Paule Lefranc; Ann-Margaret Little; Sarah Grace; Stephen Mackinnon; J Alejandro Madrigal; Paul J Travers
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

7.  Rapid T cell receptor delineation reveals clonal expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell response.

Authors:  Arumugam Balamurugan; Hwee L Ng; Otto O Yang
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

8.  Next-generation-sequencing-spectratyping reveals public T-cell receptor repertoires in pediatric very severe aplastic anemia and identifies a β chain CDR3 sequence associated with hepatitis-induced pathogenesis.

Authors:  Pina F I Krell; Susanne Reuther; Ute Fischer; Thomas Keller; Stephan Weber; Michael Gombert; Friedhelm R Schuster; Corinna Asang; Polina Stepensky; Brigitte Strahm; Roland Meisel; Jens Stoye; Arndt Borkhardt
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

9.  Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.

Authors:  Aude G Chapuis; Gunnar B Ragnarsson; Hieu N Nguyen; Colette N Chaney; Jeffrey S Pufnock; Thomas M Schmitt; Natalie Duerkopp; Ilana M Roberts; Galina L Pogosov; William Y Ho; Sebastian Ochsenreither; Matthias Wölfl; Merav Bar; Jerald P Radich; Cassian Yee; Philip D Greenberg
Journal:  Sci Transl Med       Date:  2013-02-27       Impact factor: 17.956

10.  A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Authors:  Taco W Kuijpers; Ester M M van Leeuwen; Barbara H Barendregt; Paul Klarenbeek; Daan J aan de Kerk; Paul A Baars; Machiel H Jansen; Niek de Vries; René A W van Lier; Mirjam van der Burg
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.